Andrew Dauber

25PUBLICATIONS
205CO-AUTHORS
Infant and child healthMolecular medicineNeonatologyGene expression (incl. microarray and other genome-wide approaches)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 04, 2026
A phase 3, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of vosoritide in children with hypochondroplasia: CANOPY HCH-3 study design.

|Aug 21, 2026
Diagnosis of hypochondroplasia: international Delphi consensus recommendations.

|Jun 19, 2026
Clinical burden of classic congenital adrenal hyperplasia and glucocorticoid-related complications: a claims analysis.

|Apr 12, 2026
A phase II basket trial of vosoritide in children with RASopathies, ACAN, and NPR2 deficiency.

Andrew Dauber, Anqing Zhang, Niusha Shafaei

|Feb 19, 2026
Somapacitan in children with idiopathic short stature: a randomized controlled phase 3 study.

Jennifer Abuzzahab, Andrew Dauber, Michael Højby

|Jan 16, 2026
International guideline on genetic testing of children with short stature.

Andrew Dauber, Alexander A L Jorge, Ola Nilsson

Pageof 5

Frequent Collaborators

5 joint publications

Vivian Hwa

3 joint publications

Philippe Backeljauw

3 joint publications

Roopa Kanakatti Shankar

3 joint publications

Stefano Cianfarani